TITLE

Is there a role for adjuvant therapy for resected non-small cell lung cancer?

AUTHOR(S)
Jett, James R.
PUB. DATE
August 1999
SOURCE
Thorax;Aug1999, pS37
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877210

 

Related Articles

  • Cisplatin/vinorelbine.  // Reactions Weekly;Jan2015, Vol. 1533 Issue 1, p130 

    An abstract of the article "Split-dose cisplatin and vinorelbine as adjuvant chemotherapy for completely resected non-small cell lung cancer," by F. Hirai and colleagues is presented.

  • Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer. Kato, Harubumi; Tsuboi, Masahiro; Kato, Yasufumi; Ikeda, Norihiko; Okunaka, Tetsuya; Hamada, Chikuma // International Journal of Clinical Oncology;Jun2005, Vol. 10 Issue 3, p157 

    Consensus on adjuvant therapy for completely resected non-small cell lung cancer until 2002 was as follows. (1) There was no significant impact of postoperative adjuvant chemotherapy based on meta-analysis and previous clinical trials. (2) Confirmatory studies are necessary in large-scale...

  • Highlights in management of early stage non-small cell lung cancer. Li, Grace // Journal of Thoracic Disease;Aug2013 Supplement, Vol. 5, pS339 

    The article reports that the journal "Translational Lung Cancer Research" will launch its special issue entitled "Management of Early Stage Non-Small Cell Lung Cancer." It highlights the topics of this special issue which include the treatment for Non-Small Cell Lung Cancer (NSCLC), role of...

  • Highlights in lung cancer: explore treatment and care for lung cancer with world-known experts. Li, Grace // Journal of Thoracic Disease;Aug2013 Supplement, Vol. 5, pS337 

    The article reports that the journal "Translational Lung Cancer Research" will launch its special issue entitled "Management of Early Stage Non-Small Cell Lung Cancer." It highlights the topics of this special issue which include the treatment for Non-Small Cell Lung Cancer (NSCLC), role of...

  • Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer. LOURDES, LAURA S.; JALAL, SHADIA I.; HANNA, NASSER // Oncologist;Sep2015, Vol. 20 Issue 9, p975 

    The article discusses adjuvant chemotherapy as an alternative to surgical resection in the treatment of non-small cell lung cancer (NSCLC). Topics covered include the improved survival and response rates from the use of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR TKI), the...

  • Early-Stage Lung Cancer Findings End a Debate, Put Focus on Next Steps. McNeil, Caroline // JNCI: Journal of the National Cancer Institute;7/21/2004, Vol. 96 Issue 14, p1054 

    Focuses on the significance of the adjuvant therapy in early-stage, non-small-cell lung cancer for patients. Presentation of the clinical trial of the therapy; Effects of the therapy on patients with non-small cell lung cancer; Efforts to link clinical outcomes to the biology of targeted therapies.

  • Advancements in Radiation Therapy for Medically Inoperable Early Stage Non-small Cell Lung Cancer. Kong, Feng-Ming (Spring); Chetty, Indrin J. // Current Medical Literature: Respiratory Medicine;2006, Vol. 20 Issue 3, p57 

    This section presents research which dealt with the advancements in radiation therapy for medically inoperable early stage of non-small cell lung cancer. Lung cancer is the most commonly detected cancer worldwide. In this regard, radiation therapy was proven to play an important role in the...

  • NCCN's new lung cancer guidelines called a useful reference. Fernandez, Julio // Drug Topics;2/11/2008, Vol. 152 Issue 3, p8 

    The article reports that the National Comprehensive Cancer Network (NCCN) has updated its non-small cell lung cancer guidelines. According to the author, the guidelines include a section outlining the evaluation, treatment and management of thymic malignancies. The guidelines recommend that...

  • Adjuvant chemotherapy did not improve survival in stage Ib NSCLC.  // Hem/Onc Today;12/10/2008, Vol. 9 Issue 22, p29 

    The article focuses on a study which suggested that adjuvant chemotherapy should not be considered the standard of care in stage Ib non-small cell lung cancer. In this study, researchers randomly assigned patients to adjuvant chemotherapy or observation four to eight weeks following tumor...

  • Cancer-Related Weight Loss. Palombine, Jessica // Clinical Journal of Oncology Nursing;Dec2006, Vol. 10 Issue 6, p831 

    Mr. A is a 70-year old man who was initially diagnosed with stage II colon cancer in 1990. Prior to diagnosis, he experienced an unintentional 23-pound weight loss. He underwent surgical resection, with additional surgery in 1992 for release of adhesions. He was treated with adjuvant...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics